Industry
Biotechnology
Topic
Bankruptcy
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Bankruptcy in Biotechnology
... headquarters is set to remain in Ireland. — ASSOCIATED PRESS LIFE SCIENCES Ginkgo Bioworks opening production facility Ginkgo Bioworks Inc. on Thursday will open a ...
... ��� BRISBANE, Calif., July 01, 2016 (GLOBE NEWSWIRE) -- �KaloBios Pharmaceuticals, Inc. (OTC:KBIOQ), a developmental stage biopharmaceutical company focused on advancing medicines for ...
... BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, ...
... Financially pressed Bind Therapeutics Inc. said Monday it has filed for federal bankruptcy protection after the ...
... from chapter 11.Welook forward tosatisfying the judgment resulting from the litigation with PharmAthene, Inc., focusing ongrowing our businessandsupplyingthe U.S. Government and other jurisdictions withimportantbio-threat protection,"said ...
... TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities ...
... helped lift foreign sales slowed dramatically. Irish drugmaker Shire ups bid for Baxalta TRENTON, N.J. -- Irish drugmaker Shire PLC's second attempt to buy Baxalta ...
... Cancer drug research company KaloBios Pharmaceuticals Inc. filed an emergency motion for bankruptcy protection Tuesday, less than two ...
... fired Shkreli as CEO, South San Francisco-based cancer drug research company KaloBios Pharmaceuticals Inc. filed for bankruptcy. KaloBios had taken strategic investment from Shkreli to ...
... KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO)(the "Company"), today announced that on December 29, 2015, it filed ...
... Martin Shkreli: one of the companies he ran has filed for bankruptcy. KaloBios has sought Chapter 11 protection, as the U.S. Bankruptcy Court for the ...
... affirmed the prior Court of Chancery Opinion in which the court awarded PharmAthene, Inc. approximately $195 million, including pre-judgment interest up to January 15, 2015. ...
... from chapter 11 and to continue the litigation of its dispute with PharmAthene, Inc. without posting a bond or other security, until that litigation is ...
... least $42M "Â Saratoga Resources seeks bankruptcy protection for second time "Â Baxalta prices $5B notes offering The full report follows Out of Court Luna ...
... Nirvana files for bankruptcy thanks to cash shortage and loan defaults "Â Egenix seeks approval of new DIP, opening offer for its assets "Â Sun ...
... The Company's Chapter 11 filing was precipitated by its ongoing litigation with PharmAthene, Inc. For additional information on the OTC Markets, please visit www.otcmarkets.com . ...
... the same. These are the 10 companies cutting the most jobs. 10. Amgen Inc. > Job cuts: 4,000 > Number of employees: 18,000 > 1yr. ...
... of appeal from the judgment of the Delaware Court of Chancery awarding PharmAthene, Inc. expectation damages. On January 15, 2015, the Court of Chancery entered ...
... Egenix, Inc. announced today that the Company has filed a voluntary petition under ...
... Delaware Supreme Court, issued a letter opinion in the litigation begun by PharmAthene, Inc. in 2006. The Court has directed PharmAthene to submit a revised ...
... of Chancery ruled Siga had failed to negotiate in good faith with PharmAthene Inc. over a license for the drug when it was in development ...
... issued an opinion in the litigation initiated against SIGA in 2006 by PharmAthene, Inc. In that opinion, which SIGA believes was wrongly decided, the Court ...
... and market the drug. On January 24, 2013 - Ipsen and Inspiration Biopharmaceuticals Inc. (Inspiration) announced that they entered into an Asset Purchase Agreement (APA) ...
... Amarillo Biosciences can tap DIP . Amarillo Biosciences Inc. will work to recapitalize and monetize its intellectual property with the ...
... Inspiration Biopharmaceuticals to finish liquidation . Inspiration Biopharmaceuticals Inc. has won confirmation of its liquidation plan following the sale of ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤